Pkd1 inactivation induced in adulthood produces focal cystic disease.
Autosomal dominant polycystic kidney disease, the most common monogenetic disorder, is characterized by gradual replacement of normal renal parenchyma by fluid-filled cysts. Mutations in either PKD1 or PKD2 cause autosomal dominant polycystic kidney disease. Pkd1(-/-) or Pkd2(-/-) mice develop rapid renal cystic disease and exhibit embryonic lethality; this supports the "two-hit" hypothesis, which proposes that a germline mutation in PKD1 (or PKD2) followed by a second somatic mutation later in life is responsible for the phenotype. Here, for investigation of the loss of Pkd1 at specific times of development, an inducible Pkd1-knockout mouse model was generated. Inactivation of Pkd1 in 5-wk-old mice resulted in formation of only focal renal cysts 6 to 9 wk later but in a severe polycystic phenotype nearly 1 yr later. Cysts derived from either collecting tubules or distal tubules but not from proximal tubules, which correlated with sites of Cre-mediated recombination. Inactivation of Pkd1 in 1-wk-old mice, however, resulted in massive cyst disease 6 wk later, despite a similar pattern of Cre-mediated recombination between 1- and 5-wk-old kidneys. Moreover, a germline heterozygous Pkd1 mutation facilitated cyst formation when a somatic Pkd1 mutation was induced. A marked increase in proliferating cell nuclear antigen expression was observed in cyst-lining epithelia and in normal-looking tubules adjacent to but not in those distant from cysts. These data suggest that Pkd1 inactivation is not sufficient to initiate the cell proliferation necessary for cyst formation; a paracrine mechanism may account for focal cell proliferation and regional disease progression. We propose that an additional genetic or nongenetic "third hit" may be required for rapid development of cysts in polycystic kidney disease.
Takakura
Ayumi
A
Renal Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA.
Contrino
Leah
L
Beck
Alexander W
AW
Zhou
Jing
J
D000818:Animals; D049109:Cell Proliferation; D018450:Disease Progression; D005091:Exons; D018095:Germ-Line Mutation; D006579:Heterozygote; D051379:Mice; D018345:Mice, Knockout; D009154:Mutation; D010641:Phenotype; D007690:Polycystic Kidney Diseases / Q000235:genetics*; D011995:Recombination, Genetic; D050396:TRPP Cation Channels / Q000235:genetics* / Q000502:physiology*; D019076:Transgenes
D050396:TRPP Cation Channels
Cell Prolif. 1992 Jan;25(1):31-40
1540682
Nat Med. 2007 Dec;13(12):1490-5
17965720
J Am Soc Nephrol. 2007 Jul;18(7):2143-60
17582161
Nephrol Dial Transplant. 2006 Aug;21(8):2078-84
16720597
J Intern Med. 2007 Jan;261(1):17-31
17222165
Am J Kidney Dis. 1991 Jun;17(6):634-7
2042637
Exp Nephrol. 1995 Mar-Apr;3(2):88-9
7773643
Hum Mol Genet. 2002 Jul 15;11(15):1731-42
12095915
Mod Pathol. 1988 Nov;1(6):457-63
3065782
J Clin Invest. 1996 Dec 15;98(12):2674-82
8981910
Nat Genet. 1992 Jul;1(4):235-7
1338768
Am J Pathol. 2006 Jan;168(1):205-20
16400024
Mol Cell. 1998 Aug;2(2):247-51
9734362
Arch Pathol. 1964 May;77:485-502
14120684
J Am Soc Nephrol. 2004 Dec;15(12):3035-43
15579506
J Am Soc Nephrol. 1995 Jan;5(7):1462-8
7703384
Am J Physiol. 1997 Apr;272(4 Pt 2):F451-9
9140045
Hum Mol Genet. 2001 Oct 1;10(21):2385-96
11689485
Curr Biol. 2007 Sep 18;17(18):1586-94
17825558
J Pathol Bacteriol. 1966 Apr;91(2):311-5
5918616
Kidney Int. 2008 Jun;73(12):1394-405
18385665
Nat Genet. 2003 Feb;33(2):129-37
12514735
Cell. 1996 Dec 13;87(6):979-87
8978603
Cell. 2002 Apr 19;109(2):157-68
12007403
Kidney Int. 1991 Apr;39(4):718-24
2051729
J Urol. 1995 Mar;153(3 Pt 1):578-83
7861486
Nat Cell Biol. 2005 Dec;7(12):1202-12
16311606
Hum Mol Genet. 2004 Dec 15;13(24):3069-77
15496422
Nat Genet. 1997 Oct;17(2):179-81
9326937
Lancet. 1994 Sep 17;344(8925):789-91
7916076
Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1731-6
10677526
Hum Mol Genet. 2007 Dec 15;16(24):3188-96
17932118